Susanne Muller-Knapp

Dikutip oleh

	Semua	Sejak 2020
Kutipan	19768	7574
indeks-h	63	47
indeks-i10	123	109

1600

800

400

1200

199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202579 93 161 143 153 174 154 155 182 212 183 217 318 350 311 354 386 471 568 708 943 1468 1358 1463 1403 1561 1501 1397 1420 1354 335

Akses publik

Lihat semua

113 artikel

17 artikel

tersedia

tidak tersedia

Berdasarkan pada mandat pendanaan

Pengarang bersama

Oleg FedorovUniversity of OxfordEmail yang diverifikasi di cmd.ox.ac.uk
Panagis FilippakopoulosAssociate Professor, Oxford UniversityEmail yang diverifikasi di sgc.ox.ac.uk
Paul E BrennanUniversity of OxfordEmail yang diverifikasi di cmd.ox.ac.uk
Marco Emilio BianchiSan Raffaele UniversityEmail yang diverifikasi di hsr.it
Wen Hwa LeeAction Against AMD, SGC and University of OxfordEmail yang diverifikasi di actionagainstamd.org
Brian MarsdenCentre for Medicines Discovery & Centre for Human Genetics, NDM, University of OxfordEmail yang diverifikasi di cmd.ox.ac.uk
Benedict-Tilman BergerPostDoc Biochemistry, Goethe University FrankfurtEmail yang diverifikasi di chemie.uni-frankfurt.de
Paola ScaffidiThe Francis Crick InstituteEmail yang diverifikasi di crick.ac.uk
Clarence YappHarvard Medical School, University of OxfordEmail yang diverifikasi di hms.harvard.edu
Apirat ChaikuadEmail yang diverifikasi di pharmchem.uni-frankfurt.de
Chas BountraProfessor of Translational MedicineEmail yang diverifikasi di cmd.ox.ac.uk
Tiziana BonaldiTenured Group Leader European Institute of OncologyEmail yang diverifikasi di ieo.it
Cheryl ArrowsmithSenior Scientist, Princess Margaret Cancer Centre & Professor of Medical Biophysics, University of TorontoEmail yang diverifikasi di uhnres.utoronto.ca
Opher GileadiSGC, Karolinska InstituteEmail yang diverifikasi di ki.se
Andreas KraemerGroup Leader, Structural Genomics ConsortiumEmail yang diverifikasi di pharmchem.uni-frankfurt.de
David Harold DrewryProfessor University of North Carolina Chapel HillEmail yang diverifikasi di unc.edu
anne-claude gingrasLunenfeld-Tanenbaum Research Institute; University of TorontoEmail yang diverifikasi di lunenfeld.ca
Jean-Philippe LambertUniversité LavalEmail yang diverifikasi di crchudequebec.ulaval.ca
Tim WillsonProfessor, UNC Eshelman School of Pharmacy, UNC Chapel HillEmail yang diverifikasi di unc.edu
Martin SchröderNovartis Institute for Biomedical ResearchEmail yang diverifikasi di novartis.com

Ikuti

Susanne Muller-Knapp

Goethe University Frankfurt

Email yang diverifikasi di bmls.de - Beranda

Chemical probes


Judul Urutkan menurut kutipan Urutkan menurut tahun Urutkan menurut judul	Dikutip oleh Dikutip oleh	Tahun
Histone recognition and large-scale structural analysis of the human bromodomain family P Filippakopoulos, S Picaud, M Mangos, T Keates, JP Lambert, ... Cell 149 (1), 214-231, 2012	1840	2012
The promise and peril of chemical probes CH Arrowsmith, JE Audia, C Austin, J Baell, J Bennett, J Blagg, C Bountra, ... Nature chemical biology 11 (8), 536-541, 2015	895	2015
Sp1‐mediated transcriptional activation is repressed by Sp3. G Hagen, S Müller, M Beato, G Suske The EMBO journal 13 (16), 3843-3851, 1994	876	1994
HMGB1 is an endogenous immune adjuvant released by necrotic cells P Rovere‐Querini, A Capobianco, P Scaffidi, B Valentinis, F Catalanotti, ... EMBO reports 5 (8), 825-830, 2004	759	2004
Cloning by recognition site screening of two novel GT box binding proteins: a family of Sp1 related genes G Hagen, S Müller, M Beato, G Suske Nucleic acids research 20 (21), 5519-5525, 1992	720	1992
The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells B Degryse, T Bonaldi, P Scaffidi, S Müller, M Resnati, F Sanvito, ... Journal of Cell Biology 152 (6), 1197-1206, 2001	655	2001
The double life of HMGB1 chromatin protein: architectural factor and extracellular signal S Müller, P Scaffidi, B Degryse, T Bonaldi, L Ronfani, A Agresti, ... The EMBO journal, 2001	588	2001
Bromodomains as therapeutic targets S Muller, P Filippakopoulos, S Knapp Expert reviews in molecular medicine 13, e29, 2011	567	2011
Large-scale structural analysis of the classical human protein tyrosine phosphatome AJ Barr, E Ugochukwu, WH Lee, ONF King, P Filippakopoulos, I Alfano, ... Cell 136 (2), 352-363, 2009	562	2009
RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain S Picaud, C Wells, I Felletar, D Brotherton, S Martin, P Savitsky, ... Proceedings of the National Academy of Sciences 110 (49), 19754-19759, 2013	512	2013
Regulated expression and subcellular localization of HMGB1, a chromatin protein with a cytokine function S Müller, L Ronfani, ME Bianchi Journal of internal medicine 255 (3), 332-343, 2004	499	2004
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases O Fedorov, B Marsden, V Pogacic, P Rellos, S Müller, AN Bullock, ... Proceedings of the National Academy of Sciences 104 (51), 20523-20528, 2007	424	2007
Exogenous High-Mobility Group Box 1 Protein Induces Myocardial Regeneration After Infarction via Enhanced Cardiac C-Kit⁺ Cell Proliferation and Differentiation F Limana, A Germani, A Zacheo, J Kajstura, A Di Carlo, G Borsellino, ... Circulation research 97 (8), e73-e83, 2005	403	2005
Dual kinase-bromodomain inhibitors for rationally designed polypharmacology P Ciceri, S Müller, A O'mahony, O Fedorov, P Filippakopoulos, JP Hunt, ... Nature chemical biology 10 (4), 305-312, 2014	391	2014
The (un) targeted cancer kinome O Fedorov, S Müller, S Knapp Nature chemical biology 6 (3), 166-169, 2010	381	2010
Comprehensive characterization of the published kinase inhibitor set JM Elkins, V Fedele, M Szklarz, KR Abdul Azeez, E Salah, J Mikolajczyk, ... Nature biotechnology 34 (1), 95-103, 2016	350	2016
Inhibition of BET bromodomain targets genetically diverse glioblastoma Z Cheng, Y Gong, Y Ma, K Lu, X Lu, LA Pierce, RC Thompson, S Muller, ... Clinical cancer research 19 (7), 1748-1759, 2013	345	2013
Discovery and optimization of small-molecule ligands for the CBP/p300 bromodomains DA Hay, O Fedorov, S Martin, DC Singleton, C Tallant, C Wells, S Picaud, ... Journal of the American Chemical Society 136 (26), 9308-9319, 2014	343	2014
The ins and outs of selective kinase inhibitor development S Müller, A Chaikuad, NS Gray, S Knapp Nature chemical biology 11 (11), 818-821, 2015	303	2015
PFI-1, a highly selective protein interaction inhibitor, targeting BET Bromodomains S Picaud, D Da Costa, A Thanasopoulou, P Filippakopoulos, PV Fish, ... Cancer research 73 (11), 3336-3346, 2013	300	2013

Sistem tidak dapat melakukan operasi ini. Coba lagi nanti.

Artikel 1–20

Kutipan per tahun

Kutipan duplikat

Kutipan yang digabung

Tambahkan pengarang bersamaPengarang bersama

Ikuti

Dikutip oleh

Pengarang bersama